COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma
High-level TRAE management showed a trend toward improved treatment adherence, which was statistically significant for pyrexia. Optional use of an app did not influence treatment adherence.
Authors
- Patrick Terheyden (ORCID: https://orcid.org/0000-0002-5894-1677)
- E. Dippel
- Dirk Debus
- Rudolf Alexander Herbst (ORCID: https://orcid.org/0000-0002-4238-9486)
- Christoffer Gebhardt (ORCID: https://orcid.org/0000-0001-7090-9584)
- Johannes Wohlrab (ORCID: https://orcid.org/0000-0002-3993-712X)
- Yenny Angela (ORCID: https://orcid.org/0000-0002-6643-7286)
- Michael Weichenthal (ORCID: https://orcid.org/0000-0002-9060-4961)
- Manar Aoun
- Magdalena Walecki
- Tüting Thomas
- Erwin Schultz (ORCID: https://orcid.org/0000-0003-0426-8074)
- Fabian Ziller (ORCID: https://orcid.org/0000-0002-2519-1312)
- L. M. Heinzerling
- Anca Sindrilaru (ORCID: https://orcid.org/0000-0002-1691-0047)
- Gaston Schley
- P. Dücker
- Ulrike Leiter (ORCID: https://orcid.org/0000-0002-8019-1577)
- Nessr Abu Rached (ORCID: https://orcid.org/0000-0001-6853-0743)
- Kjell M. Kaune
- C.‐D. Klemke
- R Stadler
- Jens Ulrich
- F Meier
- Sebastian Haferkampf
- Jochen Utikal
- Imke von Wasielewski
- Marc Bender
- Dirk Schadendorf
- Markus V. Heppt
- Jessica C. Hassel
- Peter Mohr
- Lisa Zimmer (ORCID: https://orcid.org/0000-0002-3680-3521)
Institutions
- Novartis (Switzerland) (CH)
- Universität Hamburg (DE)
- German Cancer Research Center (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Heidelberg University (DE)
- Ludwigshafen University of Business and Society (DE)
- University Hospitals of the Ruhr-University of Bochum (DE)
- Dorothea Dix Hospital (US)
- University Hospital Heidelberg (DE)
- University Hospital Regensburg (DE)
- Christian-Albrechts-Universität zu Kiel (DE)
- Universitätsklinikum Erlangen (DE)
- Städtisches Klinikum Karlsruhe (DE)
- Nuremberg Hospital (DE)
- Helios Hospital Schwerin (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- National Center for Tumor Diseases (DE)
- University Hospital Schleswig-Holstein (DE)
- Essen University Hospital (DE)
- Global Climate Forum (DE)
- University Cancer Center Hamburg (DE)
- Klinikum Dortmund (DE)
- Klinikum Ludwigshafen (DE)
- University Hospital Magdeburg (DE)
- Elbe Kliniken Stade-Buxtehude (DE)
- Helios Klinikum Erfurt (DE)
- Comprehensive Cancer Center Erlangen (DE)
- Klinikum Bremen-Mitte (DE)
- University Hospital Ulm (DE)
- University Medical Centre Mannheim (DE)
- University Hospital Carl Gustav Carus (DE)
- Klinikum Chemnitz (DE)
- Johannes Wesling Klinikum Minden (DE)
- Novartis Foundation (CH)
- Martin Luther University Halle-Wittenberg (DE)
- Technische Universität Dresden (DE)
- University of Tübingen (DE)
- Ludwig-Maximilians-Universität München (DE)
- Ruhr University Bochum (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- Cancers
- Published
- 2026-02-18
- DOI
- https://doi.org/10.3390/cancers18040667
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00